The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer

被引:43
|
作者
Terracciano, Daniela [1 ]
Terreri, Sara [2 ]
de Nigris, Filomena [3 ]
Costa, Valerio [2 ]
Calin, George A. [4 ,5 ,6 ]
Cimmino, Amelia [2 ]
机构
[1] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
[2] CNR, Inst Genet & Biophys A Buzzati Traverso, Via Pietro Castellino 111, I-80131 Naples, Italy
[3] Univ Campania Luigi Vanvitelli, Dept Biochem Biophys & Gen Pathol, Naples, Italy
[4] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Ctr Small Interfering RNA & Noncoding RNAs, Houston, TX 77030 USA
来源
关键词
lncRNAs; miRNAs; T-UCRs; Cancer; CPG ISLAND HYPERMETHYLATION; T-UCR; ELEMENTS; EXPRESSION; IDENTIFICATION; METASTASIS; MICRORNAS; PROSTATE; GENE; SNPS;
D O I
10.1016/j.bbcan.2017.09.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ultraconserved regions (UCRs) represent a relatively new class of non-coding genomic sequences highly conserved between human, rat and mouse genomes. These regions can reside within exons of protein-coding genes, despite the vast majority of them localizes within introns or intergenic regions. Several studies have undoubtedly demonstrated that most of these regions are actively transcribed in normal cells/tissues, where they contribute to regulate many cellular processes. Interestingly, these non-coding RNAs exhibit aberrant expression levels in human cancer cells and their expression profiles have been used as prognostic factors in human malignancies, as well as to unambiguously distinguish among distinct cancer types. In this review, we first describe their identification, then we provide some updated information about their genomic localization and classification. More importantly, we discuss about the available literature describing an overview of the mechanisms through which some transcribed UCRs (T-UCR) contribute to cancer progression or to the metastatic spread. To date, the interplay between T-UCRs and microRNAs is the most convincing evidence linking T-UCRs and tumorigenesis. The limitations of these studies and the future challenges to be addressed in order to understand the biological role of T-UCRs are also discussed herein. We envision that future efforts are needed to convincingly include this class of. ncRNAs in the growing area of cancer therapeutics.
引用
收藏
页码:449 / 455
页数:7
相关论文
共 50 条
  • [41] Long noncoding RNAs and the genetics of cancer
    S W Cheetham
    F Gruhl
    J S Mattick
    M E Dinger
    British Journal of Cancer, 2013, 108 : 2419 - 2425
  • [42] Long noncoding RNAs in cancer metastasis
    Liu, S. John
    Dang, Ha X.
    Lim, Daniel A.
    Feng, Felix Y.
    Maher, Christopher A.
    NATURE REVIEWS CANCER, 2021, 21 (07) : 446 - 460
  • [43] Long noncoding RNAs in cancer metastasis
    S. John Liu
    Ha X. Dang
    Daniel A. Lim
    Felix Y. Feng
    Christopher A. Maher
    Nature Reviews Cancer, 2021, 21 : 446 - 460
  • [44] Long noncoding RNAs and cancer, an overview
    Camacho, Cristel V.
    Choudhari, Ramesh
    Gadad, Shrikanth S.
    STEROIDS, 2018, 133 : 93 - 95
  • [45] Long Noncoding RNAs in Lung Cancer
    Roth, Anna
    Diederichs, Sven
    LONG NON-CODING RNAS IN HUMAN DISEASE, 2016, 394 : 57 - 110
  • [46] Long noncoding RNAs and their link to cancer
    Grixti, Justine M.
    Ayers, Duncan
    NON-CODING RNA RESEARCH, 2020, 5 (02): : 77 - 82
  • [47] Long noncoding RNAs and the genetics of cancer
    Cheetham, S. W.
    Gruhl, F.
    Mattick, J. S.
    Dinger, M. E.
    BRITISH JOURNAL OF CANCER, 2013, 108 (12) : 2419 - 2425
  • [48] Long Noncoding RNAs in Cancer Pathways
    Schmitt, Adam M.
    Chang, Howard Y.
    CANCER CELL, 2016, 29 (04) : 452 - 463
  • [49] Long noncoding RNAs in cancer cells
    Bach, Duc-Hiep
    Leek, Sang Kook
    CANCER LETTERS, 2018, 419 : 152 - 166
  • [50] Long noncoding RNAs in cervical cancer
    Shi, Dan
    Zhang, Cheng
    Liu, Xiaodong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (04) : 745 - 753